Dear John,

Join Health Affairs tomorrow February 25 for an exclusive Insider virtual event with Stacie Dusetzina exploring HHS’s announcement of the 15 additional drugs selected for Medicare drug price negotiations, including weight-loss drugs such as Ozempic and Wegovy.

Today's Featured Articles

From Laggard To Leader: Why Health Care In The United States Is Failing, And How To Fix It

Donald M. Berwick et al.

The Challenge Of Medicare And Medicaid Integration For Dual Eligible Individuals Under 65

Barbara Lyons et al.

part of our Medicare And Medicaid Integration series

More from the Medicare and Medicaid Integration Series

Innovating Without Compromising Integration: Considerations For Medicare

Mary Russell et al. (December 2024)

For Dually Eligible Individuals, Medicare Brokers Are 'Broken'

Michael Monson et al. (May 2024)

How The CMS Innovation Center Can Drive State Investments In Health-Related Social Needs

Maggie Samra and Matthew Kehn (December 2023)

As COVID-19 surged across the US starting in 2020, so too did the use of repurposed medications such as hydroxychloroquine and ivermectin to treat COVID-19 infections.

In an ahead-of-print article published last week, Michelle S. Rockwell and coauthors explore demographic variation in COVID-19-associated outpatient hydroxychloroquine and ivermectin use and spending throughout the public health emergency.

LIVE! with Yashaswini Singh

Join us for a live taping of A Health Podyssey on March 12 as Rob Lott chats with Yashaswini Singh about her upcoming paper in the March 2025 edition of Health Affairs and takes questions from a live audience.

This event is free for all.